Session III: Discussion DR. DAVID G. HOEL (NIEHS): My particular interest in this area is with the use of models in quantitative risk estimation. This exercise has become very popular. I am pleased to see that OSHA is even becoming involved, perhaps as a result of encouragement of judges. Also, my biases come from the area of toxicology, in terms of how we can incorporate toxicology into the risk estimation process and couple it with the epidemiology findings. The usual situation occurs when we find something in an animal study, then people say: where is the human evidence? I noticed with the pancreatic cancer and coffee findings that the statement was: but where are the animal studies?
I guess we really need both. In terms of incorporation of toxicological information, I think it will provide us with some mechanistic hypotheses which oftentimes are difficult to derive from purely epidemiological studies. The National Toxicology Program, including the NCI cancer bioassay program, is particularly interested in bringing more scientific studies into the process, as opposed to purely the testing and screening of chemicals. Along this line, I think that the epidemiologist should look to the toxicology information for those cases much within an order of magnitude. Now, these data may have been selective in terms of how it was put together, but from Meselson's total dose one can translate to a daily dose rate and obtain good agreements.
Earlier the use of dose per surface area, which relates to metabolic rates for species extrapolation was mentioned. This dose measure is much the same as dose per body weight. The important issue in all this is how one handles data from less than lifetime studies. The difficulty is that if an Armitage-Doll multistage model is appropriate, then the time factor may be a high power of duration of exposure. Now, this has an important application when we are dealing with occupational studies. For example, if we are to compare lifetime animal data with human data, which have less than lifetime exposures, how do you extrapolate out to a full lifetime?
I believe Meselson in his work assumed a multistage model with three or four stages. Therefore, we need careful modeling for that purpose. Secondly, how should we incorporate worker populations into estimating risks for a full lifetime of worker exposure, or extrapolate occupational data to environmental exposures? Dr. Wagoner mentioned exposures to vinyl chloride outside the plant and how would he make that extrapolation. By simply taking the ratio of cumulative incidence for a lifetime to a short exposure, and depending on the number of stages to be assumed in the Doll model, very large differences in relative incidence can be attained. This means that if we believe that the mechanism we are dealing with for a particular carcinogen is multistage, then we People mention that arsenic is carcinogenic in man but there are no animal data. The second compound mentioned is benzene, although Maltoni has shown positive effects in rats after oral intubation. Finally, we heard about vinyl chloride, which is probably one of the most studied chemical carcinogens in rodents. Considerable dose-response work has been done by Maltoni and other investigators. Also important pharmacokinetics work has been done by Gehring and others at Dow laboratories. These studies are all very carefully done and we have a good idea about the mechanisms and how one can model the carcinogenic effects.
With the coke oven data, because we are dealing with lung cancer, it is unfortunate that we do not have data on smoking. For example, I was curious about the rise in the relative risk over time and then the dropback. We could be dealing with some sort of susceptible subgroups that are being eliminated, given that smokers may be a possible susceptible subgroup. Also when one is calculating a risk, although there is some synergy between the coke oven and cigarette smoking, would one set risks based on the smoker or the nonsmoker? I think these are relevant problems. Also, with the termination of exposure, there has been some work by Whittemore, Day and Brown, in terms of looking at multistage models. When you stop exposure, does the risk continue as though you had not stopped it? This would be the case, for example, if it was an early stage that was affected by the material. Alternatively, does risk taper off very quickly? This would be so if it was a late stage having more of a promotional effect. These issues will be very important when one becomes involved with time extrapolation. Cigarettes, for example, appear to effect both an early and a late stage, at least from the analysis of the British doctors that Peto and Doll have been working on.
In the megamouse study at the National Center Finally, directed to all of the authors: we heard a little about cytogenetic effects with respect to benzene. Recently at NIEHS and other places there has been considerable effort in terms of developing methods for analysis of body fluids for mutagenic activity using microbial tests. There has also been considerable effort in terms of developing assays for genetic toxicity. We have the lymphocytic assay of Albertini, we have sister chromatid exchange, we have unscheduled DNA repair, we have mutant sperm assays and we are looking at mutant red cells by using fluorescent antibodies. There is a whole collection of gene-tox measures or indicators that we hope to apply to environmental groups. Now, there has not been shown a direct relationship to a health endpoint. But my question is: Is this an appropriate scientific direction for occupational epidemiology to go? I find when we are dealing purely with morbidity and mortality data, the precision and power of the tests to be frustrating. Are these gene-tox measures the approach to take to improve the precision of the detection process?
DR We are talking about long-term chronic disease. Cancers may not show up for 20 to 30 or more years. If we could in some way intervene and, perhaps, eliminate exposure or transfer the individual out for at least those carcinogens that are not only initiators but promoters as well, maybe we could accomplish something. But the whole concept of medical surveillance is to reduce the incidence of disease, and from the way that we do it in general, I don't see that taking place. It would be good if we could develop some shortterm tests to find out what is going on today with persons who are known to be exposed to carcinogens.
DR. J. K. WAGONER: Dr. Hoel raised a question with reference to the study by Brady et al. and the inability of those investigators to document, for 30 to 50% of the cases of angiosarcoma of the liver, any exposure to arsenic, thorium dioxide or vinyl chloride, three agents known to cause that disease. In response to that question I think one has to recall our experience with asbestos before arriving at any firm conclusion regarding the contribution of "idiopathic liver angiosarcoma."
It was not so many years ago that a large portion of cases of mesothelioma were reported as having no known exposure to asbestos. I believe the latest opinions on that subject by the IARC are that upwards of 80 to 90% of all mesotheliomas have an asbestos etiology. More recently Cochrane and Webster have reported that nearly 100% of all mesotheliomas have had a prior exposure to asbestos. Thus, as was clearly shown to be the case for mesothelioma, the true proportion of liver angiosarcomas having an idiopathic etiology will be determined only following more in-depth study which elicits an adequate consumer, environmental or occupational exposure history.
With regard to the significance of the study by Brady et al. to the EPA risk assessment for vinyl chloride effluents, although the study did not in-dicate any monitoring data, the findings do indirectly address that issue. However, I am led to believe that this study was not considered in the EPA decision regarding the control of vinyl chloride effluents. In light of that, EPA may wish to reassess the safety of their effluent standard.
DR. JOSEPH MEYER (Squibb Corp.): Dr. Redmond and I believe Dr. Wagoner showed some instances of a lower relative risk of cancer mortality with increasing years in the plant. Is it conceivable that this effect is partially the function of competing risks? In other words, one wonders what the relative risks would look like if they were based on net mortality rates rather than crude mortality experience. I think it is a very interesting question to know whether this apparent inverse relationship is a function of extrinsic factors, such as people dying through other causes, compared with cancer mortality rate changing as the result of some kind of intrinsic mechanism. The question is: what would these relative risks look like if they were based on a data set that was cleaned out for competing risks? As the workers get older they die due to large. The comment has to do with the effect of smoking, which I think we all agree creates difficulties in any study where it is not possible to be controlled for. If you consider the history of smoking in the U.S. population, which is often the one used as a control, one can make assumptions as to what the likelihood would be that any occupational group would have, say 70% smokers or 80% smokers, and even include the likelihood that they might have been heavier smokers than the U.S. population as a whole. I have done this exercise and it appears to me that you might get as much as a relative risk of about 1.5 for that type of comparison, but not above about 1.5.
So I think ifyou are talking about relative risks of 5 or 10 for lung cancer, you are way out of any likelihood that it could be explained by differences in smoking, and I think that is the point Dr. Redmond made earlier.
DR. REDMOND: I have a slide which I didn't show which shows for lung cancer mortality, the standardized mortality ratios of total steelworkers compared to the United States population. For white steelworkers the standardized mortality ratio is about 35% greater than the total United States ratio. For blacks it was somewhat greater than that. But if you took out the coke plant workers, where we know there is an excess risk of lung cancer, there was about 35% greater risk than the total United States lung cancer rates. That difference is possible, if virtually all of the workers were heavy smokers. For that reason, we have relied in most of our analyses on internal comparisons so we could get at the specific occupational risks. And it was only in this latter risk assessment that the general United States rates were used. I think it is fair to point out, however, that smoking may have elevated the relative risk somewhat in these occupational studies.
DR. RADFORD: My question for the panel at large is related to the difficulty in achieving control of these three agents. In the case of vinyl chloride, a shift of the occupational exposure limits from 50 parts per million to 1 part per million was accomplished readily, although not without a certain amount of difficulty, and it has been implemented quite effectively by the industry. There are other aspects to establishing a permissible exposure level. One is the feasibility for industry to get to a specified level. According to my interpretation of the Supreme Court decision-and everyone has his own interpretationif you were able to demonstrate significant risk at a level which the industry could not attain, then the standard would be set at the level the industry could attain, even though there was a subsequent significant risk associated with that exposure level.
But I think it is very important to educate workers, and, in fact, to educate the general population about carcinogens. We were talking yesterday about acceptability of risk, that workers may choose to work in areas where they are exposed to carcinogens. Well, that riay be because they have no other opportunity for employment. They are trapped. They are willing to sacrifice their lives in order to educate and feed their families so that they could have a better life. Perhaps we need to do some education in high schools. Recently I have talked to a number of men and women graduating from high schools. They know nothing or relatively little about anything that causes cancer. Education may change their pattern of decision-making. They may decide not to be a blue collar worker if they are aware of a number of substances that are known to cause cancer to which they could be exposed to in those jobs. But we are not educating high school students about occupational carcinogens, so they are making the choice after they are already into the technology and have no alternative, for the most part.
DR. WAGONER: I should like to comment on that subject. I am now serving as a consultant to the Workers Institute for Safety and Health, an affiliate of the AFL-CIO. We believe that worker education is extremely important. However, in any education program concerning risk assessment I think we must get a more open acceptance of those factors which are impediments to the free choice on the part of workers as to what they are willing to accept. We saw during the days of the vinyl chloride debate the situation of a 45-year old man sitting with his fingers crossed behind his back and saying it couldn't happen to him. This man had two children who were soon to be of college age, and he was being told that his job was in danger if industry had to close due to strict government standards. In addition this man had little opportunity for employment in another industry because under present day worker's compensation law the last employer bears liability. Clearly that man had absolutely no ability to make any free choice concerning risk assessment. The constraints of our society clearly are factors that must be removed prior to any meaningful discussion of risk assessment on the part of workers in the United States.
I also would suggest that any formal education program ought to involve the wife of the worker. I say that on the basis of a very interesting experience involving uranium miners. Recently one uranium miner who had seven girls and one boy was informed of published data showing an altered sex ratio in the offspring of uranium miners in Europe. He stated that it's one thing to get cancer by the age of 55 or 60; however, if by going underground he was going to face the traumatic danger of falling beams or the possibility of genetic damage affecting his offsp-ring, then risk assessment has no meaning to him or his family.
DR. REDMOND: I agree with the difficulties that are inherent in terms of risk assessment but I personally feel that it is very important to have strong worker education programs in terms of making clear to them what the actual risks are, as well as some of the quantitative work that is done relative to extrapolation of risk over a working lifetime. Since many of the standards are obviously not being set so that one cin assure absolute protection, workers are not involved in the process. They may not have very clear-cut choices in terms of being exposed or not being exposed, but certainly there should be a strong commitment to convey as much of that information directly to the worker as possible, as much as one can glean from the epidemiologic studies and from the quantitative risk assessment in ways that the worker himself can understand.
DR. DAVID BATES (Univ. of British Columbia, Vancouver): I would like to make one comment on the observation about sputum cytology made a moment ago. The only example I know which is encouraging in relation to sputum cytology in lung cancer is a small group of nickel workers from Sudbury, Canada, 25 men in the sintering plant. The 5-yr survival from lung cancer in situ is now significantly above predicted. Eighteen lung cancers have been prospectively diagnosed by sputum cytology. This experience has been published recently in the Journal of Cardiovascular Thoracic Surgery. But that is the' only example I know where there is encouragement with early diagnosis. There was an interesting paper in the Journal of Occupational Medicine recently on a coke oven worker who faced difficult logistic decisions when his sputum converted from normal to malignant. This is an example of a problem faced by an individual worker whose sputum converted over a 5-yr period of surveillance, resulting in detection of a pinhead-sized carcinoma and removal of a lobe of the lung. I DR. REDMOND: One of your questions had to do with the extent to which there is consistency internationally in the results that are cited or noted for coke oven workers. First, let me say we studied 12 coke plants, 11 in the United States and one in Canada. We noted quite good consistency in terms of the estimated levels of relative risk, as I tried to point out in my discussion. It is true that there are some differences among plants but the thing that one must take into account is that the sample sizes also varied considerably among plants, and from time to time the issue would be raised about a plant with a hundred workers and no lung cancers observed. This result is to be expected from the nature of the magnitude of the risk. Other factors can be the age of the plant and so on. In taking into account the consistency of the data I think we look very closely at issues like length of exposure, where people work, sample sizes, and so on, and find within our own data closer agreement than what I thought we would.
We have never noted risk as high as 250% for steelworkers in general. As I commented earlier, they seem to be around 35 and not yet published data by Maibach and by Blank. Absorption has occurred in simian and cadaver skin, the palms of human volunteers, and abraded skin in the monkey. So skin exposure of benzene can now be considered to be a relatively important route of exposure. In looking back at the exposure characteristics of the population in rubber workers, perhaps this is a factor that needs to be considered.
My other comment is that in chest films, one cubic millimeter of cancer cells is equivalent to one million cells. One cubic centimeter is equivalent to one billion cells. I think you need say no more about the sensitivity of the chest roentgenogram as a means of preventing cancer, because it is very difficult if not actually impossible to pick up a 1 mm lesion. The Bureau of Radiologic Health, I think, is beginning to compare the risks ofmedical radiation with the benefit ofthis sort of examination. I think their feeling about it is negative at this point.
You did mention another chemical, and that is acrylonitrile. I point out that O'Berg's study, in its original and incomplete form, did indicate an increased colon cancer. When it was eventually published in July 1980, an increased incidence did not appear: there is apparently no increase in colon cancer in the populations of acrylonitrile workers who have been studied. I don't imply that these studies are satisfactorily adequate from an epidemiologic standpoint, but there doesn't appear to be any positive data.
The last thing, Dr. Wagoner, the question of manifestation and exposure, the Sixth Circuit Court of Appeals within the last several months has ruled that exposure is the prevailing doctrine rather than manifestation. Consequently the employee who was exposed a long time ago is at a different risk with regard to the way he would be handled or treated from an employment or compensation standpoint, at least in the area where the doctrine would prevail.
DR 
